vs
AMERICAN WOODMARK CORP（AMWD）とPrestige Consumer Healthcare Inc.（PBH）の財務データ比較。上の社名をクリックして会社を切り替えられます
AMERICAN WOODMARK CORPの直近四半期売上が大きい（$394.6M vs $283.4M、Prestige Consumer Healthcare Inc.の約1.4倍）。Prestige Consumer Healthcare Inc.の純利益率が高く（16.5% vs 1.5%、差は14.9%）。Prestige Consumer Healthcare Inc.の前年同期比売上増加率が高い（-2.4% vs -12.8%）。Prestige Consumer Healthcare Inc.の直近四半期フリーキャッシュフローが多い（$75.3M vs $638.0K）。過去8四半期でPrestige Consumer Healthcare Inc.の売上複合成長率が高い（1.2% vs -3.3%）
アメリカン・ウッドマーク社はキッチン・バスルーム用キャビネットの製造メーカーで、本社はバージニア州ウィンチェスターに置かれています。同社は全米各地に複数の生産拠点とサービスセンターを展開しており、生産拠点はアリゾナ、ジョージアなど8州に分布し、サービスセンターは全米各地に設置されています。
プレステージ・コンシューマー・ヘルスケア社はアメリカの企業で、一般用医薬品のヘルスケア製品および家庭用洗浄製品の販売・流通を手がけています。1996年にMedtech Products社、Prestige Brands International社、Spic and Span社の合併により設立され、本社はニューヨーク州タリータウン、バージニア州リンチバーグに製造工場を構えています。
AMWD vs PBH — 直接比較
損益計算書 — Q2 FY2026 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $394.6M | $283.4M |
| 純利益 | $6.1M | $46.7M |
| 粗利率 | 15.2% | 55.5% |
| 営業利益率 | 3.1% | 29.1% |
| 純利益率 | 1.5% | 16.5% |
| 売上前年比 | -12.8% | -2.4% |
| 純利益前年比 | -78.0% | -23.5% |
| EPS（希薄化後） | $0.42 | $0.97 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $394.6M | $283.4M | ||
| Q3 25 | $403.0M | $274.1M | ||
| Q2 25 | $400.4M | $249.5M | ||
| Q1 25 | $397.6M | $296.5M | ||
| Q4 24 | $452.5M | $290.3M | ||
| Q3 24 | $459.1M | $283.8M | ||
| Q2 24 | $453.3M | $267.1M | ||
| Q1 24 | $422.1M | $277.0M |
| Q4 25 | $6.1M | $46.7M | ||
| Q3 25 | $14.6M | $42.2M | ||
| Q2 25 | $25.6M | $47.5M | ||
| Q1 25 | $16.6M | $50.1M | ||
| Q4 24 | $27.7M | $61.0M | ||
| Q3 24 | $29.6M | $54.4M | ||
| Q2 24 | $26.8M | $49.1M | ||
| Q1 24 | $21.2M | $49.5M |
| Q4 25 | 15.2% | 55.5% | ||
| Q3 25 | 16.7% | 55.3% | ||
| Q2 25 | 17.0% | 56.2% | ||
| Q1 25 | 15.0% | 57.3% | ||
| Q4 24 | 18.9% | 55.5% | ||
| Q3 24 | 20.2% | 55.5% | ||
| Q2 24 | 18.6% | 54.7% | ||
| Q1 24 | 19.2% | 54.8% |
| Q4 25 | 3.1% | 29.1% | ||
| Q3 25 | 5.0% | 29.1% | ||
| Q2 25 | 7.4% | 28.8% | ||
| Q1 25 | 5.3% | 29.8% | ||
| Q4 24 | 9.4% | 31.7% | ||
| Q3 24 | 10.2% | 29.7% | ||
| Q2 24 | 8.4% | 27.0% | ||
| Q1 24 | 6.6% | 29.7% |
| Q4 25 | 1.5% | 16.5% | ||
| Q3 25 | 3.6% | 15.4% | ||
| Q2 25 | 6.4% | 19.0% | ||
| Q1 25 | 4.2% | 16.9% | ||
| Q4 24 | 6.1% | 21.0% | ||
| Q3 24 | 6.5% | 19.2% | ||
| Q2 24 | 5.9% | 18.4% | ||
| Q1 24 | 5.0% | 17.9% |
| Q4 25 | $0.42 | $0.97 | ||
| Q3 25 | $1.00 | $0.86 | ||
| Q2 25 | $1.73 | $0.95 | ||
| Q1 25 | $1.09 | $1.00 | ||
| Q4 24 | $1.79 | $1.22 | ||
| Q3 24 | $1.89 | $1.09 | ||
| Q2 24 | $1.70 | $0.98 | ||
| Q1 24 | $1.32 | $0.98 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $52.1M | $62.4M |
| 総負債低いほど良い | $363.3M | $1.0B |
| 株主資本純資産 | $928.2M | $1.8B |
| 総資産 | $1.6B | $3.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.39× | 0.56× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $52.1M | $62.4M | ||
| Q3 25 | $54.9M | $119.1M | ||
| Q2 25 | $48.2M | $139.5M | ||
| Q1 25 | $43.5M | $97.9M | ||
| Q4 24 | $56.7M | $50.9M | ||
| Q3 24 | $89.3M | $51.5M | ||
| Q2 24 | $87.4M | $34.3M | ||
| Q1 24 | $97.8M | $46.5M |
| Q4 25 | $363.3M | $1.0B | ||
| Q3 25 | $364.8M | $993.1M | ||
| Q2 25 | $365.8M | $992.7M | ||
| Q1 25 | $367.3M | $992.4M | ||
| Q4 24 | $368.0M | $992.0M | ||
| Q3 24 | $372.2M | $1.1B | ||
| Q2 24 | $371.8M | $1.1B | ||
| Q1 24 | $371.3M | $1.1B |
| Q4 25 | $928.2M | $1.8B | ||
| Q3 25 | $920.3M | $1.8B | ||
| Q2 25 | $916.0M | $1.9B | ||
| Q1 25 | $919.6M | $1.8B | ||
| Q4 24 | $915.1M | $1.8B | ||
| Q3 24 | $913.8M | $1.7B | ||
| Q2 24 | $910.4M | $1.7B | ||
| Q1 24 | $896.9M | $1.7B |
| Q4 25 | $1.6B | $3.5B | ||
| Q3 25 | $1.6B | $3.4B | ||
| Q2 25 | $1.6B | $3.4B | ||
| Q1 25 | $1.6B | $3.4B | ||
| Q4 24 | $1.6B | $3.3B | ||
| Q3 24 | $1.6B | $3.3B | ||
| Q2 24 | $1.6B | $3.3B | ||
| Q1 24 | $1.6B | $3.3B |
| Q4 25 | 0.39× | 0.56× | ||
| Q3 25 | 0.40× | 0.54× | ||
| Q2 25 | 0.40× | 0.54× | ||
| Q1 25 | 0.40× | 0.54× | ||
| Q4 24 | 0.40× | 0.55× | ||
| Q3 24 | 0.41× | 0.61× | ||
| Q2 24 | 0.41× | 0.65× | ||
| Q1 24 | 0.41× | 0.68× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $11.2M | $78.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $638.0K | $75.3M |
| FCFマージンFCF / 売上 | 0.2% | 26.6% |
| 設備投資強度設備投資 / 売上 | 2.7% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 1.83× | 1.68× |
| 直近12ヶ月FCF直近4四半期 | $64.0M | $267.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $11.2M | $78.3M | ||
| Q3 25 | $33.1M | $57.5M | ||
| Q2 25 | $44.8M | $79.0M | ||
| Q1 25 | $11.0M | $61.8M | ||
| Q4 24 | $11.9M | $65.1M | ||
| Q3 24 | $40.8M | $69.8M | ||
| Q2 24 | $43.3M | $54.8M | ||
| Q1 24 | $43.7M | $66.9M |
| Q4 25 | $638.0K | $75.3M | ||
| Q3 25 | $25.3M | $55.4M | ||
| Q2 25 | $35.8M | $78.2M | ||
| Q1 25 | $2.3M | $58.4M | ||
| Q4 24 | $1.1M | $63.5M | ||
| Q3 24 | $29.5M | $67.8M | ||
| Q2 24 | $7.2M | $53.6M | ||
| Q1 24 | $22.1M | $63.8M |
| Q4 25 | 0.2% | 26.6% | ||
| Q3 25 | 6.3% | 20.2% | ||
| Q2 25 | 8.9% | 31.3% | ||
| Q1 25 | 0.6% | 19.7% | ||
| Q4 24 | 0.2% | 21.9% | ||
| Q3 24 | 6.4% | 23.9% | ||
| Q2 24 | 1.6% | 20.1% | ||
| Q1 24 | 5.2% | 23.0% |
| Q4 25 | 2.7% | 1.1% | ||
| Q3 25 | 1.9% | 0.8% | ||
| Q2 25 | 2.2% | 0.3% | ||
| Q1 25 | 2.2% | 1.2% | ||
| Q4 24 | 2.4% | 0.5% | ||
| Q3 24 | 2.5% | 0.7% | ||
| Q2 24 | 8.0% | 0.4% | ||
| Q1 24 | 5.1% | 1.1% |
| Q4 25 | 1.83× | 1.68× | ||
| Q3 25 | 2.27× | 1.36× | ||
| Q2 25 | 1.75× | 1.66× | ||
| Q1 25 | 0.66× | 1.23× | ||
| Q4 24 | 0.43× | 1.07× | ||
| Q3 24 | 1.38× | 1.28× | ||
| Q2 24 | 1.62× | 1.12× | ||
| Q1 24 | 2.06× | 1.35× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMWD
| Home Center Retailers | $166.7M | 42% |
| Builders | $164.7M | 42% |
| Independent Dealersand Distributors | $63.2M | 16% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
